Research Updates

There is evidence that the lens extraction and replacement method used for cataract treatment may be a viable option for primary closed-angle glaucoma as well.

Researchers are still in the early stages of exploring how this information can be turned into new glaucoma treatments.

“I am a researcher because I am driven to understand disease in order to treat it and be able to help people.”
– Tonia Rex, PhD

Dr. Goldberg talks about the Catalyst for a Biomarker Imitative and its impact on glaucoma research.

Dr. Goldberg’s research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, as well as stem cell and nanotherapeutic approaches to repair damaged eyes.

Researchers are working on some amazing things that artificial intelligence (AI) can do for glaucoma sufferers, especially in the areas of diagnosis and disease management, but it will take time and more work.

Matrix metalloproteinases (or MMPs) may sound like something out of a sci-fi story, but they’re a real-life family of enzymes—the metzincin superfamily—that thrive inside the human body.

Researchers are developing a new type of glasses that contain a prism that will redirect the sight of a person with limited peripheral vision.